Breaking News Instant updates and real-time market news.

TMUS

T-Mobile

$45.27

-0.23 (-0.51%)

, SSNLF

Samsung

$1,350.00

-250 (-15.63%)

06:06
10/10/16
10/10
06:06
10/10/16
06:06

T-Mobile halting sales of Samsung Galaxy Note 7

T-Mobile (TMUS) has decided to halt sales of the Samsung (SSNLF) Galaxy Note 7 after "a number" of replacement phones caught fire. T-Mobile says, "While Samsung investigates multiple reports of issues, T-Mobile is temporarily suspending all sales of the new Note7 and exchanges for replacement Note7 devices. Customers can still bring their recalled Note7 or the new replacement Note7, along with accessories they purchased from T-Mobile, to a T-Mobile store for a full refund and choose from any device in T-Mobile's inventory. We'll waive any restocking charges, and customers who purchased during pre-order can keep the free Netflix subscription and Gear Fit or SD card they received." T-Mobile is the second major U.S. carrier, after AT&T (T), to cease selling the product.

TMUS

T-Mobile

$45.27

-0.23 (-0.51%)

SSNLF

Samsung

$1,350.00

-250 (-15.63%)

VZ

Verizon

$49.92

-0.34 (-0.68%)

T

AT&T

$38.87

-0.24 (-0.61%)

  • 20

    Oct

  • 23

    Oct

  • 24

    Oct

  • 07

    Nov

  • 14

    Nov

  • 13

    Dec

TMUS T-Mobile
$45.27

-0.23 (-0.51%)

09/21/16
PACS
09/21/16
NO CHANGE
PACS
T-Mobile should be bought at current levels, says Pacific Crest
Pacific Crest analyst Michael Bowen says that investors may be concerned about T-Mobile's failure to raise its annual guidance despite strong preliminary Q3 subscription metrics. Bowen says that strong iPhone 7 promotions could weigh on the company's margins, but he thinks that adding customers, taking market share and increasing service revenue are more important for the company. He recommends buying the stock and keeps a $53 price target and Overweight rating on the shares.
09/15/16
FBCO
09/15/16
NO CHANGE
Target $150
FBCO
Outperform
Credit Suisse raises Apple iPhone estimates on survey, carrier comments
Credit Suisse analyst Kulbinder Garcha said that build plans noted by the firm's tech team in Japan, the firm's proprietary iPhone survey and recent announcements from Sprint (S) and T-Mobile (TMUS) all lead him to now believe that Apple's (AAPL) iPhone 7 cycle may be stronger than anticipated. Accordingly, Garcha increased his calendar year 2016 iPhone volume estimate to 215M from 208M and took his calendar year 2017 estimate up to 221M units from 217M units. Additionally, two recent surveys conducted by the firm point to a potential beneficial mix shift, as more buyers appear to be shifting toward the Plus model compared to the mix in the iPhone 6s cycle, Garcha tells investors. The analyst reiterates an Outperform rating and $150 price target on Apple shares, which closed yesterday at $111.77.
09/13/16
WELS
09/13/16
NO CHANGE
WELS
Market Perform
Apple iPhone 7 strength consistent with view, says Wells Fargo
Wells Fargo analyst Maynard Um says the iPhone 7 pre-order strength announced by T-Mobile (TMUS) and Sprint (S) is consistent with his view that "aggressive carrier promotions" should help to drive sales of the next generation phone. Um still expects Apple's multiple expansion to be limited given the "limited visibility and some concern into the March quarter." The analyst keeps a Market Perform rating on Apple shares with a $105-$120 price target range.
09/20/16
PIPR
09/20/16
NO CHANGE
PIPR
Overweight
Piper survey shows decline in iPhone upgrade interest
Piper Jaffray analyst Gene Munster says his firm's survey of 403 U.S. iPhone owners suggests that interest in an iPhone 7 upgrade declined after the announcement of the device. The data contradicts "generally positive" initial demand indicators including from carriers including T-Mobile (TMUS) and Sprint (S), Munster tells investors in a research note. The analyst questions iPhone 7 demand into Apple's (AAPL) March and June quarters but remains confident in his thinking for flattish growth for iPhone 7 versus iPhone 6. Munster reiterates an Overweight rating on Apple.
SSNLF Samsung
$1,350.00

-250 (-15.63%)

08/01/16
NEED
08/01/16
NO CHANGE
Target $65
NEED
Buy
Synaptics price target lowered to $65 from $88 at Needham
Needham analyst Rajvindra Gill lowered his price target for Synaptics (SYNA) to $65 from $88 on a lower earnings multiple as he remains uncertain on whether the company has secured the OLED DDIC for Apple's (AAPL) iPhone 8 versus an internal Samsung (SSNLF) solution. The analyst reiterates a Buy rating on Synaptics' shares, saying the company will remain one of the leaders in the display markets.
06/23/16
BFIN
06/23/16
NO CHANGE
BFIN
Fitbit faces 'fight of its life,' GoPro Karma delay a problem, says BlueFin
In an update on the wearable space, BlueFin analysts John Donovan and Steve Mullane make the case that Fitbit (FIT) is "in for the fight of its life" given mounting competition that is coming from Samsung (SSNLF), Apple (AAPL), Garmin (GRMN) and Under Armour (UA), adding that the sizable inventory of Alta and Blaze devices that it must deplete in this competitive environment puts Fitbit is in a "precarious position." The analyst add that Apple's watchOS improvements "further paint Fitbit into a corner," but noted that market data suggests consumers are looking for wearables under $200, which is in the "sweet spot" of Fitbit's portfolio. Weighing in on GoPro (GPRO), the analysts wonder if the Hero5 will be compelling enough to make consumers buy another camera and note that its upcoming Karma drone is very late to market and "facing daunting odds."
04/26/16
NEED
04/26/16
NO CHANGE
NEED
Apple supply chain names to rebound, says Needham
Needham analyst Rajvindra Gill expects a rebound in the Apple (AAPL) supply chain names given its underperformance over the last 25 days and the relatively good quarterly results from Knowles (KN). Among the names, the analyst sees Cirrus Logic (CRUS) increasing its dollar content per unit about 40% for the iPhone 7 cycle, with possible upside of 80%-100% for the iPhone 7S in 2017 with the inclusion of adaptive noise cancellation. Knowles, which generated 25% of sales from Apple and less than 10% of sales from Samsung (SSNLF), posted better-than-expected results and guidance, the analyst tells investors in a research note.
04/13/16
ROTH
04/13/16
NO CHANGE
Target $2.6
ROTH
Buy
Digital Turbine estimates, price target reduced at Roth Capital
Roth Capital analyst Brian Alger reduced his estimates for Digital Turbine (APPS) and lowered his price target on the shares to $2.60 from $3, after the company quantified the miss that it had previewed last month. The shortfall was attributed to the slashed digital ad budget of a large advertising customer, Verizon (VZ) choosing to reduce the number of slots per device for much of the March quarter, and to Verizon Samsung S7's (SSNLF) that have yet to have Ignite software included, the analyst tells investors in a research note. Alger reiterates a Buy rating on Digital Turbine's shares, considering the depressed current valuation.
VZ Verizon
$49.92

-0.34 (-0.68%)

09/23/16
RHCO
09/23/16
NO CHANGE
RHCO
Yahoo hack is probably not a material adverse change, says SunTrust
After Yahoo (YHOO) reported that over 500M of its accounts had been hacked, SunTrust analyst Robert Peck thinks that the news is probably not a material adverse change, or MAC, that would jeopardize the company's acquisition by Verizon (VZ). He notes that the sales contract says that a MAC will not be triggered by "any failure by Yahoo to meet its internal or published projections, budgets, plans, or forecasts of its revenues, earnings, or other financial performance or results of operations." The analyst says that the hack "may be manageable," since a majority of the victims could be e-mail users who are sticky. He keeps a Neutral rating on Yahoo.
09/23/16
BOFA
09/23/16
NO CHANGE
Target $55
BOFA
Buy
BofA thinks Verizon deal stays on track despite Yahoo data breach
Bank of America Merrill Lynch analyst Justin Post said that Yahoo's (YHOO) disclosure of the massive data breach impacting over 500M of its users is clearly a negative for the company that could result in email account closures, but he does not anticipate a major impact on Yahoo's business related to this breach, citing as evidence the fact that he is not aware of any significant business impairment or financial liability related to security breaches at LinkedIn (LNKD) in 2012 and at eBay (EBAY) in 2014. Post adds that the Target (TGT) data breach, which did include credit card info, is not directly comparable to Yahoo's breach. For Verizon (VZ) to back out of its acquisition agreement, Post thinks the company would need to assume Yahoo acted in bad faith during negotiations and that the Yahoo asset is impaired or comes with significant liability, neither of which he sees as being the case. The analyst keeps a Buy rating on Yahoo and bumped his target on the shares to $55 from $53, citing an increased price target on Alibaba (BABA) that a peer at the firm recently set.
09/19/16
WELS
09/19/16
NO CHANGE
WELS
Concerns about Frontier Communications leverage overdone, says Wells Fargo
Wells Fargo says that some investors have expressed concern about Frontier's leverage ratio. Specifically, the firm says there are some worries that if Frontier has difficulty integrating the Verizon (VZ) assets it purchased, it may trigger bank covenants. However, Wells says that Frontier's synergy realization and subscription outlook have improved since Q2. Wells adds that the company's dividend is "very secure neat-term," and it keeps an Outperform rating on the shares.
09/06/16
RHCO
09/06/16
NO CHANGE
Target $18
RHCO
Neutral
SunTrust sees 'limited' list of Twitter suitors, says activist action unlikely
SunTrust analyst Robert Peck reiterated his belief that Twitter (TWTR) is unlikely to sell itself in 2016 in a new note to investors, but noted that investors have asked him who would be interested if Twitter were open to a sale. While giving his opinion on potential acquirers - which he sees possibly including Google (GOOG), Facebook (FB), Apple (AAPL), Amazon (AMZN), Microsoft (MSFT), AT&T (T), Verizon (VZ), Disney (DIS), Fox (FOXA), and Alibaba (BABA) - Peck said the company's high price and "unique" asset limit the potential buyers and gave his view that a PE buyer is highly unlikely given the company's lack of free cash flow. Additionally, Peck thinks activist action at Twitter seems "extremely unlikely" despite "unsubstantiated investor conjecture" and media reports. The analyst keeps Neutral rating and $18 price target on Twitter shares.
T AT&T
$38.87

-0.24 (-0.61%)

09/26/16
09/26/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AT&T (T) upgraded to Hold from Reduce at HSBC. 2. Potash (POT) upgraded to Positive from Neutral at Susquehanna with analyst Don Carson citing expected benefits from the company's proposed merger with Agrium (AGU), which he sees as having relatively low antitrust risk compared to the other mega-mergers being pursued in the Ag space. 3. Oshkosh (OSK) upgraded to Overweight from Neutral at JPMorgan and to Neutral from Underperform at Credit Suisse. 4. Marriott (MAR) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Thomas Allen citing strong unit growth. 5. NetApp (NTAP) upgraded to Buy from Hold at Cross Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/28/16
UBSW
09/28/16
DOWNGRADE
Target $43
UBSW
Neutral
AT&T downgraded to Neutral from Buy at UBS
UBS analyst John Hodulik downgraded AT&T to Neutral citing expectations for lower earnings growth. The analyst reduced his earnings estimates by 3% to reflect the "increased competitive intensity" in wireless and incremental costs associated with AT&T's DTV Now roll-out. Hodulik cut his price target for AT&T shares to $43 from $46.
09/28/16
09/28/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) downgraded to Underperform from Neutral at Wedbush with analyst James Dix citing concerns that the "Four Horsemen of the Search Apocalypse" -- self-identified consumers, consumer control of IP-delivered ads, payments innovation, and attention markets -- might arrive. 2. AT&T (T) downgraded to Neutral from Buy at UBS with analyst John Hodulik citing expectations for lower earnings growth. 3. Macy's (M) downgraded to Neutral from Outperform at Credit Suisse with analyst Michael Exstein saying the retailer, after outlining in August its operations and merchandising strategies, is now in an execution phase. 4. Twitter (TWTR) downgraded to Underperform from Neutral at Mizuho and to Sell from Hold at Loop Capital. 5. Galectin Therapeutics (GALT) downgraded to Sell from Buy at Roth Capital with analyst Sa'ar Yaniv citing the company's announcement that NASH-FX, GR-MD-02's Phase 2a study in NASH fibrosis, failed both primary and secondary endpoints. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/16
FBNS
10/06/16
INITIATION
Target $69.24
FBNS
Outperform
AMC Networks initiated with an Outperform at FBN Securities
FBN Securities analyst Robert Routh initiated AMC Networks (AMCX) with an Outperform rating and a fair value estimate of $69.24. Routh calls AMC Networks "very attractive" as a possible takeover target, as he believes it could fit well with either the soon-to-be-combined Lionsgate (LGF)-Starz (STRZA) or with AT&T's (T) DTV division. Routh added that reports have indicated that AT&T is looking to grow its portfolio of TV content through deals.

TODAY'S FREE FLY STORIES

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

15:17
12/04/16
12/04
15:17
12/04/16
15:17
Hot Stocks
Juno Therapeutics reports Phase 1 data on JCAR014 »

Juno Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

15:09
12/04/16
12/04
15:09
12/04/16
15:09
Conference/Events
Juno Therapeutics to host analyst and investor meeting »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRA

Atara Biotherapeutics

$18.90

-0.3 (-1.56%)

15:04
12/04/16
12/04
15:04
12/04/16
15:04
Hot Stocks
Atara Biotherapeutics reports presentation of Phase 2 CMV-CTL data »

Atara Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCI

Johnson Controls

$45.32

-0.41 (-0.90%)

15:03
12/04/16
12/04
15:03
12/04/16
15:03
Conference/Events
Johnson Controls to hold a meeting »

Strategic Review &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$297.19

1.41 (0.48%)

14:59
12/04/16
12/04
14:59
12/04/16
14:59
Hot Stocks
Biogen reports data presentations on hemophilia treatments Eloctate, Alprolix »

Biogen and Swedish Orphan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMSF

Genmab

14:58
12/04/16
12/04
14:58
12/04/16
14:58
Conference/Events
Genmab to hold data review meeting »

Management discusses data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$764.46

0.13 (0.02%)

, GOOG

Alphabet

$750.50

2.58 (0.34%)

14:53
12/04/16
12/04
14:53
12/04/16
14:53
Hot Stocks
Alphabet subsidiary Verily launches utensil product »

Alphabet subsidiary…

GOOGL

Alphabet Class A

$764.46

0.13 (0.02%)

GOOG

Alphabet

$750.50

2.58 (0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jan

KYN

Kayne Anderson

$19.52

0.07 (0.36%)

14:48
12/04/16
12/04
14:48
12/04/16
14:48
Hot Stocks
Kayne Anderson reports net assets $2.2B as of November 30 »

Reports net asset value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KED

Kayne Anderson

$19.29

0.03 (0.16%)

14:47
12/04/16
12/04
14:47
12/04/16
14:47
Hot Stocks
Kayne Anderson reports net assets $205M as of November 30 »

Reports net asset value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COH

Coach

$36.23

-0.05 (-0.14%)

, BURBY

Burberry

$18.08

0.265 (1.49%)

14:37
12/04/16
12/04
14:37
12/04/16
14:37
Periodicals
Burberry rejected multiple approaches from Coach, FT says »

Burberry (BURBY) rejected…

COH

Coach

$36.23

-0.05 (-0.14%)

BURBY

Burberry

$18.08

0.265 (1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNCFF

UniCredit

$2.22

0.03 (1.37%)

, AMP

Ameriprise

$113.47

-1.57 (-1.36%)

14:31
12/04/16
12/04
14:31
12/04/16
14:31
Periodicals
UniCredit to sell asset manager to Amundi for over EUR 3B, FT says »

UniCredit (UNCFF) is set…

UNCFF

UniCredit

$2.22

0.03 (1.37%)

AMP

Ameriprise

$113.47

-1.57 (-1.36%)

FIG

Fortress

$5.10

-0.1 (-1.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

RXN

Rexnord

$20.27

-0.72 (-3.43%)

14:09
12/04/16
12/04
14:09
12/04/16
14:09
Hot Stocks
Trump targets Rexnord over Mexico relocation plans, says 'no more' »

President-elect Donald…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$38.61

-0.27 (-0.69%)

, TWX

Time Warner

$93.80

-0.34 (-0.36%)

13:57
12/04/16
12/04
13:57
12/04/16
13:57
Periodicals
DirecTV NOW unlikely to make money, Barron's says »

AT&T's (T)…

T

AT&T

$38.61

-0.27 (-0.69%)

TWX

Time Warner

$93.80

-0.34 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

  • 07

    Dec

ARCH

Arch Coal

$79.32

1.6 (2.06%)

13:27
12/04/16
12/04
13:27
12/04/16
13:27
Periodicals
Arch Coal could gain 75%, Barron's says »

Arch Coal, which emerged…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$101.50

-1.2 (-1.17%)

13:12
12/04/16
12/04
13:12
12/04/16
13:12
Periodicals
Deere could keep climbing, Barron's says »

Deere stock recently…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$9.81

0.28 (2.94%)

, GME

GameStop

$24.27

-0.37 (-1.50%)

12:57
12/04/16
12/04
12:57
12/04/16
12:57
Periodicals
Corporate tax cut can't save all retailers, Barron's says »

Though President-elect…

JCP

J.C. Penney

$9.81

0.28 (2.94%)

GME

GameStop

$24.27

-0.37 (-1.50%)

AEO

American Eagle

$16.17

-0.57 (-3.41%)

TJX

TJX

$77.10

-0.57 (-0.73%)

FL

Foot Locker

$74.23

0.55 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 09

    Jan

ELY

Callaway Golf

$11.68

-0.3 (-2.50%)

12:40
12/04/16
12/04
12:40
12/04/16
12:40
Periodicals
Callaway Golf investors should take profits, Barron's says »

It "looks like a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVC

Entravision

12:36
12/04/16
12/04
12:36
12/04/16
12:36
Periodicals
Entravision shares could reach $9, Barron's says »

Hispanic-focused…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

GOOG

Alphabet

$750.50

2.58 (0.34%)

, GOOGL

Alphabet Class A

$764.46

0.13 (0.02%)

12:26
12/04/16
12/04
12:26
12/04/16
12:26
Periodicals
Barron's picks top ten stocks for 2017 »

Selecting its ten…

GOOG

Alphabet

$750.50

2.58 (0.34%)

GOOGL

Alphabet Class A

$764.46

0.13 (0.02%)

AAPL

Apple

$109.90

0.41 (0.37%)

C

Citi

$56.02

-1.25 (-2.18%)

DAL

Delta Air Lines

$48.31

0.54 (1.13%)

DTEGY

Deutsche Telekom

$15.65

0.14 (0.90%)

MRK

Merck

$61.13

0.37 (0.61%)

NVS

Novartis

$68.17

0.42 (0.62%)

TOL

Toll Brothers

$29.32

0.18 (0.62%)

UL

Unilever; also tag UN

$39.67

0.5 (1.28%)

UN

Unilever; also tag UL

$39.47

0.35 (0.89%)

DIS

Disney

$98.50

-0.44 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 12

    Dec

  • 15

    Jan

  • 26

    Jan

  • 08

    Mar

  • 13

    Mar

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

10:55
12/04/16
12/04
10:55
12/04/16
10:55
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$108.14

-1.86 (-1.69%)

10:55
12/04/16
12/04
10:55
12/04/16
10:55
Syndicate
Breaking Syndicate news story on Diamondback Energy »

Diamondback Energy files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

, ESALY

Eisai

$57.91

0.59 (1.03%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
American Epilepsy Society to hold annual meeting »

70th Annual Meeting of…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

ESALY

Eisai

$57.91

0.59 (1.03%)

GWPH

GW Pharmaceuticals

$112.32

3.04 (2.78%)

IART

Integra LifeSciences

$75.78

-1.07 (-1.39%)

MDT

Medtronic

$72.01

0.13 (0.18%)

MNK

Mallinckrodt

$53.61

0.51 (0.96%)

NVTA

Invitae

$6.95

0.16 (2.36%)

SAGE

SAGE Therapeutics

$49.02

-0.23 (-0.47%)

WTKWY

Wolters Kluwer

$34.08

-0.39 (-1.13%)

ZGNX

Zogenix

$13.05

0.35 (2.76%)

ZYNE

Zynerba

$13.64

0.83 (6.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 14

    Dec

  • 28

    Jan

  • 27

    Apr

CELG

Celgene

$117.63

-1.24 (-1.04%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
Celgene to hold an analyst and investor event »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

INCY

Incyte

$102.02

2.09 (2.09%)

, PFE

Pfizer

$31.63

0.17 (0.54%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
Canaccord biotech analyst to hold a dinner meeting »

In conjunction with the…

INCY

Incyte

$102.02

2.09 (2.09%)

PFE

Pfizer

$31.63

0.17 (0.54%)

LLY

Eli Lilly

$67.71

1.74 (2.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

  • 15

    Dec

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

, KITE

Kite Pharma

$50.76

0.04 (0.08%)

21:25
12/03/16
12/03
21:25
12/03/16
21:25
Conference/Events
Canaccord biotech analyst to hold a dinner meeting »

In conjunction with the…

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

KITE

Kite Pharma

$50.76

0.04 (0.08%)

BLUE

bluebird bio

$69.75

1.1 (1.60%)

NVS

Novartis

$68.17

0.42 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 03

    Dec

  • 06

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.